Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 months.
Saved in:
| Title: | Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 months. |
|---|---|
| Authors: | Masrori P; Department of Neurology, Antwerp University Hospital, Edegem, Belgium., Vaesen Bentein H; Master of Medicine Student, KU Leuven, Leuven, Belgium., Raskin J; Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium. Electronic address: jo.raskin@uza.be., Montagna M; Department of Neurology, Antwerp University Hospital, Edegem, Belgium., De Picker L; Department of Psychiatry, Antwerp University Hospital, Edegem, Belgium., De Volder I; Department of Psychiatry, Antwerp University Hospital, Edegem, Belgium; Centre for Sleep, Antwerp University Hospital, Edegem, Belgium., Van Schil PE; Department of Thoracovascular Surgery, Antwerp University Hospital, Edegem, Belgium., Janssens A; Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium., Mercelis R; Department of Neurology, Antwerp University Hospital, Edegem, Belgium. |
| Source: | Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2021 Mar; Vol. 153, pp. 117-119. Date of Electronic Publication: 2021 Jan 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
